A.R.T. Advisors, LLC - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 126 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$624,000
+83.5%
173,211
+36.6%
0.03%
+63.2%
Q2 2019$340,000
+128.2%
126,811
+152.1%
0.02%
+111.1%
Q1 2019$149,000
-46.2%
50,311
-33.2%
0.01%
-30.8%
Q3 2018$277,000
-59.8%
75,296
-59.5%
0.01%
-53.6%
Q1 2018$689,000
+79.9%
185,913
+39.7%
0.03%
+64.7%
Q4 2017$383,000
+3.2%
133,113
+60.9%
0.02%
-10.5%
Q3 2017$371,000
-38.1%
82,713
-36.6%
0.02%
-40.6%
Q2 2017$599,000
+698.7%
130,550
+613.4%
0.03%
+700.0%
Q4 2016$75,000
-83.0%
18,300
-66.4%
0.00%
-97.2%
Q3 2016$440,000
+22.2%
54,400
+16.5%
0.14%
+787.5%
Q1 2016$360,000
-86.8%
46,679
-88.2%
0.02%
-84.2%
Q3 2015$2,727,000
+28.9%
394,723
+65.2%
0.10%
+42.3%
Q2 2015$2,116,000
+33.6%
238,879
+48.7%
0.07%
+29.1%
Q1 2015$1,584,000
-42.8%
160,678
-28.9%
0.06%
-46.6%
Q4 2014$2,768,000
-59.8%
225,971
-67.2%
0.10%
-67.6%
Q3 2014$6,878,000
+763.0%
689,243
+161.0%
0.32%
+639.5%
Q3 2013$797,000
-67.1%
264,070
-10.9%
0.04%
-45.6%
Q2 2013$2,424,000296,3740.08%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q1 2018
NameSharesValueWeighting ↓
RA Capital Management 13,633,220$57,396,0007.04%
HealthInvest Partners AB 497,807$2,096,0003.21%
BVF INC/IL 3,285,400$13,832,0002.35%
EMORY UNIVERSITY 486,438$2,048,0001.93%
Marcus Capital, LLC 69,400$1,751,0001.63%
DAFNA Capital Management LLC 196,500$827,0000.70%
Orbimed Advisors 13,107,200$55,181,0000.62%
Rock Springs Capital Management LP 1,500,000$6,315,0000.36%
Spark Investment Management LLC 710,100$2,989,0000.19%
TURNER INVESTMENTS LLC 65,420$275,0000.18%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders